Figure 1From: Present and future evolution of advanced breast cancer therapy Eastern Cooperative Oncology Group 2100 trial. Phase III study of paclitaxel with or without bevacizumab. (a) Progression-free survival. (b) Overall survival. mo, months.Back to article page